サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1451503

爪真菌症治療市場レポート：疾患タイプ、治療タイプ、薬剤クラス別、流通チャネル、地域別、2024-2032

Onychomycosis Treatment Market Report by Disease Type, Treatment Type, Drug Class, Distribution Channel, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 143 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
爪真菌症治療市場レポート：疾患タイプ、治療タイプ、薬剤クラス別、流通チャネル、地域別、2024-2032
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

爪真菌症治療の世界市場規模は2023年に35億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけて4.6%の成長率（CAGR）を示し、2032年までに52億米ドルに達すると予測しています。

爪真菌症は、指の爪や足の爪に発生する真菌感染症で、不快感や慢性的な痛み、醜状につながる可能性があります。爪甲真菌症には、近位爪下、白色表在性、遠位爪下があります。爪水虫患者によくみられる爪感染症で、皮膚糸状菌、酵母、非皮膚糸状菌のカビなど様々な生物によって引き起こされます。爪甲真菌症は、爪の形の歪み、悪臭、白色から黄褐色の変色、爪のもろさ、ボロボロ、ガサガサといった症状が特徴です。通常、カリウム、酸素、水素（KOH）検査、培養、爪切りや爪生検の病理組織学的検査によって診断され、レーザー治療、薬物治療、光線力学的治療によって治療されます。

爪真菌症治療の市場動向：

爪真菌症、ヒト免疫不全ウイルス（HIV）、糖尿病、末梢動脈疾患（PAD）などの慢性疾患の有病率の増加は、市場の成長を促進する重要な要因の1つです。さらに、循環障害や免疫力の低下を起こしやすい老年人口の増加が、市場の成長を後押ししています。爪真菌症はまた、公共のスイミングプールに入る機会が増え、窮屈で汚染された、または汚れた衣服、靴、靴下を使用するため、ミレニアル世代や成人の間で非常に流行しています。さらに、経口投与が可能な水溶性抗真菌治療液の市場開拓が市場成長の推進力となっています。これらは細菌の二次感染を防ぎ、真菌の増殖を防ぐのに役立ちます。その他、爪の衛生状態を維持するために外用ネイルラッカーや軟膏が広く利用されていること、ヘルスケアインフラの大幅な改善などが、市場の成長を後押しすると予測されます。

本レポートで扱う主な質問

  • 2023年の爪真菌症治療の世界市場規模は？
  • 2024年から2032年にかけての爪真菌症治療薬世界市場の予想成長率は？
  • 爪真菌症治療の世界市場を牽引する主要因は何か？
  • COVID-19が爪真菌症治療の世界市場に与えた影響は？
  • 疾患タイプ別爪真菌症治療世界市場の内訳は？
  • 治療タイプ別爪真菌症治療世界市場の内訳は？
  • 爪真菌症治療世界市場の流通チャネル別区分は？
  • 爪真菌症治療の世界市場における主要地域は？
  • 爪真菌症治療の世界市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 爪真菌症治療の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：疾患タイプ別

  • 遠位爪甲下爪真菌症
    • 市場動向
    • 市場予測
  • 近位爪甲下爪真菌症
    • 市場動向
    • 市場予測
  • 表在性白色爪真菌症
    • 市場動向
    • 市場予測
  • カンジダ性爪真菌症
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：治療タイプ別

  • レーザー治療
    • 市場動向
    • 市場予測
  • 光線力学的療法
    • 市場動向
    • 市場予測
  • 薬物治療
    • 市場動向
    • 市場予測

第8章 市場内訳：薬剤クラス別

  • アリルアミン
    • 市場動向
    • 市場予測
  • アゾール
    • 市場動向
    • 市場予測
  • グリセオフルビン
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：流通チャネル別

  • 病院・クリニック
    • 市場動向
    • 市場予測
  • オンラインストア
    • 市場動向
    • 市場予測
  • 小売薬局
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Bausch Health Companies Inc.
    • Cipla Limited
    • Dr. Reddy's Laboratories
    • Galderma SA
    • GlaxoSmithKline PLC
    • Kaken Pharmaceutical Co. Ltd
    • Lumenis Ltd
    • Moberg Pharma AB
    • Novartis AG
    • Pfizer Inc.
    • The OTC Lab B.V.
図表

List of Figures

  • Figure 1: Global: Onychomycosis Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Onychomycosis Treatment Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Onychomycosis Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Onychomycosis Treatment Market: Breakup by Disease Type (in %), 2023
  • Figure 5: Global: Onychomycosis Treatment Market: Breakup by Treatment Type (in %), 2023
  • Figure 6: Global: Onychomycosis Treatment Market: Breakup by Drug Class (in %), 2023
  • Figure 7: Global: Onychomycosis Treatment Market: Breakup by Distribution Channel (in %), 2023
  • Figure 8: Global: Onychomycosis Treatment Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Onychomycosis Treatment (Distal Subungual Onychomycosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Onychomycosis Treatment (Distal Subungual Onychomycosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Onychomycosis Treatment (Proximal Subungual Onychomycosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Onychomycosis Treatment (Proximal Subungual Onychomycosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Onychomycosis Treatment (White Superficial Onychomycosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Onychomycosis Treatment (White Superficial Onychomycosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Onychomycosis Treatment (Candidal Onychomycosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Onychomycosis Treatment (Candidal Onychomycosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Onychomycosis Treatment (Other Disease Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Onychomycosis Treatment (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Onychomycosis Treatment (Laser Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Onychomycosis Treatment (Laser Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Onychomycosis Treatment (Photodynamic Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Onychomycosis Treatment (Photodynamic Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Onychomycosis Treatment (Drug Treatment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Onychomycosis Treatment (Drug Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Onychomycosis Treatment (Allylamine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Onychomycosis Treatment (Allylamine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Onychomycosis Treatment (Azole) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Onychomycosis Treatment (Azole) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Onychomycosis Treatment (Griseofulvin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Onychomycosis Treatment (Griseofulvin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Onychomycosis Treatment (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Onychomycosis Treatment (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Onychomycosis Treatment (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Onychomycosis Treatment (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Onychomycosis Treatment (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Onychomycosis Treatment (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Onychomycosis Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Onychomycosis Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Onychomycosis Treatment (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Onychomycosis Treatment (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: North America: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: North America: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: United States: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: United States: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Canada: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Canada: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Asia-Pacific: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Asia-Pacific: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: China: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: China: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Japan: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Japan: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: India: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: India: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: South Korea: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: South Korea: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Australia: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Australia: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Indonesia: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Indonesia: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Others: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Others: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Europe: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Europe: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Germany: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Germany: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: France: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: France: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: United Kingdom: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: United Kingdom: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Italy: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Italy: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Spain: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Spain: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Russia: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Russia: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Others: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Others: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Latin America: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Latin America: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Brazil: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Brazil: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Mexico: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Mexico: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Others: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Others: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Middle East and Africa: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Middle East and Africa: Onychomycosis Treatment Market: Breakup by Country (in %), 2023
  • Figure 89: Middle East and Africa: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: Global: Onychomycosis Treatment Industry: SWOT Analysis
  • Figure 91: Global: Onychomycosis Treatment Industry: Value Chain Analysis
  • Figure 92: Global: Onychomycosis Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Onychomycosis Treatment Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Onychomycosis Treatment Market Forecast: Breakup by Disease Type (in Million US$), 2024-2032
  • Table 3: Global: Onychomycosis Treatment Market Forecast: Breakup by Treatment Type (in Million US$), 2024-2032
  • Table 4: Global: Onychomycosis Treatment Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
  • Table 5: Global: Onychomycosis Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 6: Global: Onychomycosis Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Onychomycosis Treatment Market: Competitive Structure
  • Table 8: Global: Onychomycosis Treatment Market: Key Players
目次
Product Code: SR112024A4877

The global onychomycosis treatment market size reached US$ 3.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.2 Billion by 2032, exhibiting a growth rate (CAGR) of 4.6% during 2024-2032.

Onychomycosis is a fungal infection that occurs in the fingernails and toenails that can lead to discomfort, chronic pain and disfigurement. Proximal subungual, white superficial and distal subungual are some of the types of onychomycosis. It is a common nail infection in patients with athlete's foot and is caused by various organisms, such as dermatophytes, yeasts and non-dermatophyte molds. Onychomycosis is characterized by symptoms, including distortion in the shape of nails, foul smell, whitish to yellow-brown discoloration and brittle, ragged and crumbly texture of the nails. It is usually diagnosed through potassium, oxygen and hydrogen (KOH) examination, culture and histopathological examinations of nail clippings and nail biopsies and is treated through laser therapy, drugs and photodynamic therapies.

Onychomycosis Treatment Market Trends:

The increasing prevalence of chronic medical ailments, such as onychomycosis, human immunodeficiency virus (HIV), diabetes and peripheral artery disease (PAD), is one of the key factors driving the growth of the market. Moreover, the rising geriatric population, which is highly prone to circulatory disorders and weakened immune system, is providing a thrust to the market growth. Onychomycosis is also highly prevalent among millennials and adults due to the increased exposure to public swimming pools and utilization of tight, contaminated or soiled clothes, shoes and socks. Additionally, the development of water-soluble antifungal treatment solutions that can be administered orally is providing a thrust to the market growth. They aid in preventing secondary bacterial infections and prevent the growth of fungus. Other factors, including the widespread utilization of topical nail lacquers and ointments to maintain nail hygiene, along with the significant improvements in the healthcare infrastructure, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global onychomycosis treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on disease type, treatment type, drug class and distribution channel.

Breakup by Disease Type:

Distal Subungual Onychomycosis

Proximal Subungual Onychomycosis

White Superficial Onychomycosis

Candidal Onychomycosis

Others

Breakup by Treatment Type:

Laser Therapy

Photodynamic Therapy

Drug Treatment

Breakup by Drug Class:

Allylamine

Azole

Griseofulvin

Others

Breakup by Distribution Channel:

Hospitals and Clinics

Online Stores

Retail Pharmacies

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Bausch Health Companies Inc., Cipla Limited, Dr. Reddy's Laboratories, Galderma SA, GlaxoSmithKline PLC, Kaken Pharmaceutical Co. Ltd, Lumenis Ltd, Moberg Pharma AB, Novartis AG, Pfizer Inc. and The OTC Lab B.V.

Key Questions Answered in This Report

  • 1. What was the size of the global onychomycosis treatment market in 2023?
  • 2. What is the expected growth rate of the global onychomycosis treatment market during 2024-2032?
  • 3. What are the key factors driving the global onychomycosis treatment market?
  • 4. What has been the impact of COVID-19 on the global onychomycosis treatment market?
  • 5. What is the breakup of the global onychomycosis treatment market based on the disease type?
  • 6. What is the breakup of the global onychomycosis treatment market based on the treatment type?
  • 7. What is the breakup of the global onychomycosis treatment market based on the distribution channel?
  • 8. What are the key regions in the global onychomycosis treatment market?
  • 9. Who are the key players/companies in the global onychomycosis treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Onychomycosis Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Disease Type

  • 6.1 Distal Subungual Onychomycosis
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Proximal Subungual Onychomycosis
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 White Superficial Onychomycosis
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Candidal Onychomycosis
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Treatment Type

  • 7.1 Laser Therapy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Photodynamic Therapy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Drug Treatment
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Drug Class

  • 8.1 Allylamine
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Azole
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Griseofulvin
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Online Stores
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Retail Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Bausch Health Companies Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Cipla Limited
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Dr. Reddy's Laboratories
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Galderma SA
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 GlaxoSmithKline PLC
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Kaken Pharmaceutical Co. Ltd
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 Lumenis Ltd
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 SWOT Analysis
    • 15.3.8 Moberg Pharma AB
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Novartis AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 The OTC Lab B.V.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio